Lundbeck establishes research centre in China
14 October 2011 | By H. Lundbeck A/S
For the first time ever, H. Lundbeck A/S has established its own research centre in China...
List view / Grid view
News
Risk Evaluation and Mitigation Strategy program for FENTORA and ACTIQ
13 October 2011 | By Cephalon Inc
Healthcare professionals who prescribe & dispense FENTORA® & ACTIQ® can enroll in the REMS program...
Amgen appoints Robert A. Bradway to the Company’s Board of Directors
13 October 2011 | By Amgen
Amgen announced that its Board of Directors has appointed Robert A. Bradway to the Company's Board...
Humana and Pfizer form research partnership to improve health care delivery for seniors
13 October 2011 | By Pfizer
New research collaboration will leverage data & experience to improve seniors’ well-being...
Merck’s ISENTRESS® (raltegravir) in combination therapy demonstrated virological and immunological efficacy versus the efavirenz regimen at 192 weeks of treatment
13 October 2011 | By Merck
Exploratory pre-specified analyses from the ongoing STARTMRK Phase III study results...
Tecan and Attana extend distribution agreement
12 October 2011 | By kdm communications
Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology...
Radiometer’s AQT90 FLEX aids point of care D-dimer testing at Frimley Park
11 October 2011 | By kdm communications limited
Frimley Park Hospital in Surrey, UK, has recently invested in Radiometer’s AQT90 FLEX system...
The Omega Series with ACU – Complete and individual control of O2 and CO2 in your microplate reader
11 October 2011 | By BMG LABTECH
BMG LABTECH now offers the Atmospheric Control Unit (ACU)...
Study shows that Roche’s investigational drug for Alzheimer’s disease removes amyloid plaques from the brain1
10 October 2011 | By Roche
Monoclonal antibody gantenerumab removes amyloid plaques from the brain...
Victoza® now available to people with type 2 diabetes in China
10 October 2011 | By Novo Nordisk
Victoza® (liraglutide injection), is now commercially available in China...
AstraZeneca increases investment in China with new $200 million manufacturing facility
10 October 2011 | By AstraZeneca
AstraZeneca announced a $200 million investment in a new manufacturing facility...
bioMérieux increases pharmaceutical culture media production capacity
7 October 2011 | By bioMérieux
bioMérieux, is expanding its culture media expertise center in Craponne (France)...
Cialis® for once daily use now FDA approved
7 October 2011 | By Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil) tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis…
Teva UK Limited launches Olanzapine range
7 October 2011 | By Teva UK Ltd
Teva UK Ltd announce the off-patent launch of generic Olanzapine Teva Film-Coated Tablets & Olanzapine Teva Orodispersible Tablets...
FDA approves Merck’s JUVISYNC™ (sitagliptin and simvastatin) tablets
7 October 2011 | By Merck
Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol...
